🔎 Trials Near Me

Akèy › Neoplazmi myeloproliferatif › Alabama › Birmingham

Etid klinik pou Neoplazmi myeloproliferatif nan Birmingham, AL

8 etid pou Neoplazmi myeloproliferatif ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05564390

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
Laj 18 a 59 · Tout sèks · Mizajou Sep 22, 2026 · NCT05554406

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Alabama, Birmingham
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • University of Alabama At Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07441694

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Birmingham
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

Ap rekriteFaz 2
  • University of Alabama at Birmingham, Birmingham
Laj 18 a 75 · Tout sèks · Mizajou Oct 8, 2025 · NCT06265584

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

Ap rekriteFaz 2
  • University of Alabama at Birmingham, Birmingham
Laj 18 a 60 · Tout sèks · Mizajou Oct 8, 2025 · NCT06315309

Etid Neoplazmi myeloproliferatif nan lòt vil

Lòt etid nan Birmingham

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.